SUNSHINE BIOPHARMA INC (SBFM) Stock Analyst Ratings
USA - NASDAQ:SBFM - US8677817004 - Common Stock
1.95 USD
+0.1 (+5.41%)
1.9 USD
-0.05 (-2.56%)
ChartMill assigns a Buy % Consensus number of 83% to SBFM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.14. This target is 266.15% above the current price.
SBFM was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SBFM.
In the previous month the buy percentage consensus was at a similar level.
SBFM was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-08 | Aegis Capital | Reiterate | Buy -> Buy |
| 2024-12-05 | Aegis Capital | Reiterate | Buy -> Buy |
| 2023-08-07 | Aegis Capital | Initiate | Buy |
SUNSHINE BIOPHARMA INC / SBFM FAQ
Can you provide the average price target for SUNSHINE BIOPHARMA INC stock?
7 analysts have analysed SBFM and the average price target is 7.14 USD. This implies a price increase of 266.15% is expected in the next year compared to the current price of 1.95.
What is the consensus rating for SBFM stock?
The consensus rating for SUNSHINE BIOPHARMA INC (SBFM) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.